HL7 Terminology
2.1.29 - Continuous Process Integration (ci build)

HL7 Terminology, published by HL7 International - Vocabulary Work Group. This is not an authorized publication; it is the continuous build for version 2.1.29). This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

NamingSystem: Health Canada Drug Id Number

Summary

Defining URLhttp://terminology.hl7.org/NamingSystem/v3-hc-din
NameHcDIN
Statusactive
Definition

A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics:

  • manufacturer
  • product name
  • active ingredient(s)
  • strength(s) of active ingredient(s)
  • pharmaceutical form, and
  • route of administration.

Note: The number has a leading zero.

Further information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html

PublisherHL7

Identifiers

TypeValuePreferredPeriodComment
OID2.16.840.1.113883.5.1105true
URIhttp://terminology.hl7.org/CodeSystem/ca-hc-dintrue2021-03-12 --> (ongoing)Official canonical URL going forward.
URIhttp://hl7.org/fhir/NamingSystem/ca-hc-dinfalseMaintained for backward compatibility.
URIhttp://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database-3falseMaintained for backward compatibility.